Uh-Oh Labs has developed an innovative diagnostics platform centered around its UOL COVID-19 Test, which utilizes a patented chemistry known as Loop-de-Loop™ RT-LAMP. This technology allows for PCR-quality testing without the need for complex equipment, enabling rapid results—positive results can be delivered in as little as 12 minutes, while negative results take about 40 minutes. The test boasts a high accuracy rate of 96.1% when compared to highly sensitive PCR tests, and it offers analytical sensitivity that is over 20,000 times greater than some commercially available rapid antigen tests. The simplicity of the testing process is enhanced by an easy workflow that requires only an anterior nasal swab and can be set up in under five minutes.

In addition to the UOL COVID-19 Test, Uh-Oh Labs is also developing further diagnostic tests that leverage the Loop-de-Loop™ platform, aiming to provide accessible, lab-grade results at lower costs. The UOL COVID-19 Instrument is a reusable, ultra-portable device designed to run these molecular tests, while the UOL DxPro iOS app facilitates clear and shareable results, along with integration capabilities for patient registration and automated reporting. Supported by significant institutions and investors, including the National Institute of Health’s RADx initiative and Y Combinator, Uh-Oh Labs is committed to making accurate diagnostics more accessible and efficient for various healthcare needs.

United States

Uh-Oh Labs is a medical technology company that develops diagnostic tests through their Loop-de-Loop platform, offering simplicity, speed, and lower costs for accurate lab-grade results.

Uh-Oh Labs

Company Details